These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8834158)

  • 1. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity.
    Brady HR; Serhan CN
    Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):20-7. PubMed ID: 8834158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM; Brady HR
    Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation.
    Brady HR; Papayianni A; Serhan CN
    Trends Cardiovasc Med; 1995; 5(5):186-92. PubMed ID: 21232258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosanoids in leukocyte function.
    Serhan CN
    Curr Opin Hematol; 1994 Jan; 1(1):69-77. PubMed ID: 9371262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of leukotrienes and lipoxygenases in glomerular injury.
    Nassar GM; Badr KF
    Miner Electrolyte Metab; 1995; 21(4-5):262-70. PubMed ID: 7565475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications.
    Kowal-Bielecka O; Kowal K; Distler O; Gay S
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):43-51. PubMed ID: 17203008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
    Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():433-55. PubMed ID: 12432935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosanoids in asthma.
    Wan KS; Wu WF
    Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxins in chronic inflammation.
    Kantarci A; Van Dyke TE
    Crit Rev Oral Biol Med; 2003; 14(1):4-12. PubMed ID: 12764016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.